SHOCKWAVE MEDICAL INC (SWAV)       187.32  -2.17 (-1.15%)

187.32  -2.17 (-1.15%)

US82489T1043 - Common Stock - After market: 187.32 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 264.69. This target is 41.3% above the current price.
SWAV was analyzed by 14 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about SWAV.
In the previous month the buy percentage consensus was at a similar level.
SWAV was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 187.32166.65271.32264.69336.00 - -11.03% 44.84% 41.30% 79.37%

Up and Down Grades

Date Firm Action Rating
2023-01-26 Piper Sandler Maintains Overweight
2023-01-06 Morgan Stanley Maintains Equal-Weight
2022-12-12 Wells Fargo Downgrade Overweight -> Equal-Weight
2022-11-08 Wells Fargo Maintains Overweight
2022-10-11 Morgan Stanley Maintains Equal-Weight
2022-09-06 Oppenheimer Downgrade Perform -> Underperform
2022-08-29 Piper Sandler Maintains Overweight
2022-08-09 Wells Fargo Maintains Overweight
2022-08-09 Morgan Stanley Maintains Equal-Weight
2022-08-09 Piper Sandler Maintains Overweight
2022-07-15 Morgan Stanley Maintains Equal-Weight
2022-05-10 SVB Leerink Maintains Outperform
2022-05-10 Wells Fargo Maintains Overweight
2022-05-10 Morgan Stanley Maintains Equal-Weight
2022-02-18 SVB Leerink Maintains Outperform
2022-02-18 Morgan Stanley Maintains Equal-Weight
2022-01-07 Morgan Stanley Maintains Equal-Weight
2021-12-06 Wells Fargo Upgrade Equal-Weight -> Overweight
2021-11-09 SVB Leerink Maintains Outperform
2021-11-09 Wells Fargo Maintains Equal-Weight
2021-08-10 SVB Leerink Maintains Outperform
2021-08-10 Morgan Stanley Maintains Equal-Weight
2021-07-15 SVB Leerink Initiate Outperform
2021-07-12 B of A Securities Downgrade Buy -> Neutral
2021-06-18 Wells Fargo Downgrade Overweight -> Equal-Weight
2021-06-07 Wells Fargo Maintains Overweight
2021-05-11 Wells Fargo Maintains Overweight
2021-05-11 Canaccord Genuity Maintains Buy
2021-05-11 B of A Securities Upgrade Neutral -> Buy
2021-05-11 Morgan Stanley Maintains Equal-Weight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA